Watch and track your favorite playlist.
Curated by: Ben Bikman (139 videos)
📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: LDL cholesterol is a weak predictor of heart disease compared to markers of insulin resistance, metabolic syndrome, and the triglyceride-to-HDL ratio. True cardiovascular risk is driven far more by metabolic dysfunction than by cholesterol numbers alone. Summary: In this episode, Ben challenges the long-standing belief that LDL cholesterol is the primary driver of heart disease. While LDL has dominated cardiovascular conversations for decades, large-scale data show that nearly half of people hospitalized with heart disease have “normal” LDL levels. Instead, the strongest predictors of cardiovascular risk — especially premature heart disease — are markers of metabolic dysfunction, particularly insulin resistance. Measures like the lipoprotein insulin resistance (LP-IR) score, type 2 diabetes status, metabolic syndrome, and even the simple triglyceride-to-HDL ratio dramatically outperform LDL cholesterol in predicting who will develop heart disease. One of the most practical tools discussed is the triglyceride-to-HDL ratio, which can be calculated from a standard lipid panel. This ratio reflects underlying insulin resistance and small, dense LDL particles far better than LDL levels alone. Dr. Bikman also reviews the modest benefits of statins in primary prevention and highlights a critical point: lowering LDL does not address the root metabolic dysfunction driving cardiovascular disease. In fact, statin use — particularly in women — may increase the risk of developing type 2 diabetes. The takeaway is clear: cardiovascular prevention should shift from being LDL-centric to metabolism-centric. Insulin sensitivity, triglycerides, HDL, fasting insulin, and glycemic control are far more powerful indicators of risk than LDL cholesterol alone. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 00:55 — Rethinking the LDL Narrative 02:05 — Massive Study: Heart Attacks with Normal LDL 03:14 — Why LDL Looks Weak Compared to Metabolic Markers 04:27 — Lipoprotein Insulin Resistance (LP-IR) Score Explained 05:38 — Diabetes, Metabolic Syndrome & Premature Heart Disease 06:52 — Introducing the Triglyceride-to-HDL Ratio 07:46 — Identifying Insulin Resistance from a Standard Lipid Panel 08:55 — Ratio Cutoffs & What They Mean 09:58 — The Copenhagen Male Study 11:03 — Same LDL, Very Different Risk 12:02 — Threefold Differences in Heart Disease Incidence 13:08 — Why LDL Alone Tells You Almost Nothing 14:18 — Evidence Across Populations 15:25 — Sex Differences in Cardiovascular Risk 16:39 — Statins & Primary Prevention Data 17:43 — The Modest Impact of LDL Lowering 18:45 — Statins & Increased Diabetes Risk 19:52 — Shifting from LDL-Centric to Metabolism-Centric 21:06 — HDL as a Metabolic Marker 22:22 — The Profound Takeaway: What Really Matters NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions. #MetabolicHealth #HeartDisease #InsulinResistance #Triglycerides #HDL #LDL #CardiovascularHealth #MetabolicSyndrome #Type2Diabetes #FastingInsulin #HOMAIR #CholesterolMyths #Statins #PreventHeartDisease #LowCarbScience #KetoScience #DrBenBikman #MetabolismMatters #PrematureHeartDisease #InsulinSensitivity Ben’s favorite yerba mate and fiber: https://ufeelgreat.com/usa/en/c/1BA884 Exogenous ketones: A high-quality option is the NSF-certified goBHB from Clean Form Nutrition, where you can use the code BEN10 for a 10% discount: https://cleanformnutrition.com/products/go-bhb Ben’s favorite meal-replacement shake: https://gethlth.com (discount: BEN10)